Cardiac involvement in small and medium-sized vessel vasculitides

Lupus

Volumn 14, Issue 9, 2005, Pages 718-722

  Pagnoux, Christian ^a   Guillevin, L ^a  

^a Université Paris ^*  (France)

Author keywords

Cardiomyopathy; Churg Strauss syndrome; Heart involvement; Systemic necrotizing vasculitis; Wegener's granulomatosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CD20 ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AORTA DISSECTING ANEURYSM; CARDIOMYOPATHY; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CRYOGLOBULINEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART; HEART ARRHYTHMIA; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; INTRACARDIAC THROMBOSIS; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; VASCULITIS; WEGENER GRANULOMATOSIS;

BLOOD VESSELS; HEART; HUMANS; MYOCARDIUM; PROGNOSIS; VASCULITIS;

EID: 26244445580     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2207oa     Document Type: Review

References (30)

1. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
2. Chumbley LC, Harrison EG Jr, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977; 52: 477-484.
3. Holsinger D, Osmundson P, Edward J. The heart in periarteritis nodosa. Circulation 1962; 25: 610-618.
4. Forstot JZ, Overlie PA, Neufeld GK, Harmon CE, Forstot SL. Cardiac complications of Wegener granulomatosis: a case report of complete heart block and review of the literature. Semin Arthritis Rheum 1980; 10: 148-154.
5. Lanham JG, Cooke S, Davies J, Hughes GR. Endomyocardial complications of the Churg-Strauss syndrome. Postgrad Med J 1985; 61: 341-344.
6. Frohnert P, Sheps S. Long term follow-up study of periarteritis nodosa. Am J Med 1967; 43: 8-14.
7. Schrader ML, Hochman JS, Bulkley BH. The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 1985; 109: 1353-1359.
8. Leung DY, Schlievert PM, Meissner HC. The immunopathogenesis and management of Kawasaki syndrome. Arthritis Rheum 1998; 41: 1538-1547.
9. Hasley PB, Follansbee WP, Coulehan JL. Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. Am Heart J 1990; 120: 996-999.
10. Schiavone WA, Ahmad M, Ockner SA. Unusual cardiac complications of Wegener's granulomatosis. Chest 1985; 88: 745-748.
11. Blétry O, Godeau P, Charpentier G, Guillevin L, Herreman G. Cardiac manifestations of periarteritis nodosa. Incidence of non-hypertensive cardiomyopathy [in French]. Arch Mal Coeur Vaiss 1980; 73: 1027-1036.
12. Marette P, Molle B, Mas JL et al. Angina without involvement of large coronary trunks and precapillary pulmonary hypertension in a patient with periarteritis nodosa [in French]. Ann Cardiol Angéiol (Paris) 1989; 38: 305-308.
13. Kussmaul A, Maier R. Ueber eine bisher nicht beschriebene eigenthümliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med 1866; 1: 484-518.
14. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958; 2: 265-270.
15. Goodfield NE, Bhandari S, Plant WD, Morley-Davies A, Sutherland GR. Cardiac involvement in Wegener's granulomatosis. Br Heart J 1995; 73: 110-115.
16. Morelli S, Gurgo Di Castelmenardo AM, Conti F et al. Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int 2000; 19: 209-212.
17. Churg J, Strauss L. Allergic angiitis and periarteritis nodosa. Am J Pathol 1951; 27: 277-301.
18. Terasaki F, Hayashi T, Hirota Y et al. Evolution to dilated cardiomyopathy from acute eosinophilic pancarditis in Churg-Strauss syndrome. Heart Vessels 1997; 12: 43-48.
19. Hellemans S, Dens J, Knockaert D. Coronary involvement in the Churg-Strauss syndrome. Heart 1997; 77: 576-578.
20. Morgan JM, Raposo L, Gibson DG. Cardiac involvement in Churg-Strauss syndrome shown by echocardiography. Br Heart J 1989; 62: 462-466.
21. Henderson RA, Hasleton P, Hamid BN. Recurrence of Churg-Strauss vasculitis in a transplanted heart. Br Heart J 1993; 70: 553.
22. Guillevin L, Durand-Gasselin B, Cevallos R et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-430.
23. Ferri C, Greco F, Longombardo G et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9: 621-624.
24. Rieu V, Cohen P, Andre MH et al. Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford) 2002; 41: 290-300.
25. Smedema JP, van Paassen P, van Kroonenburgh MJ, Snoep G, Crijns HJ, Tervaert JW. Cardiac involvement of Churg-Strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol 2004; 22: S75-78.
26. Guillevin L, Lhote F, Gayraud M et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17-28.
27. Guillevin L, Cohen P, Mahr A. Arène JP, Mouthon L, Puéchal X. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucoeorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003; 49: 93-100.
28. Guillevin L. Virus-induced systemic vasculitides: new therapeutic approaches. Clin Dev Immunol 2004; 11: 227-231.
29. Jayne D. How to induce remission in primary systemic vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 293-305.
30. Stone JH, for the Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005; 352: 351-361.